Clinical Trial Update: Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial of pemetrexed plus apatinib maintenance in advanced non-squamous non-small cell lung cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Advanced Non-squamous Non-small-cell Lung Cancer | Phase 4 | Status: WITHDRAWN